Cargando…

Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier

A tight relationship between gut-liver diseases and brain functions has recently emerged. Bile acid (BA) receptors, bacterial-derived molecules and the blood-brain barrier (BBB) play key roles in this association. This study was aimed to evaluate how non-alcoholic fatty liver disease (NAFLD) and non...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiaschini, Noemi, Mancuso, Mariateresa, Tanori, Mirella, Colantoni, Eleonora, Vitali, Roberta, Diretto, Gianfranco, Lorenzo Rebenaque, Laura, Stronati, Laura, Negroni, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697805/
https://www.ncbi.nlm.nih.gov/pubmed/36430732
http://dx.doi.org/10.3390/ijms232214254
_version_ 1784838659297509376
author Fiaschini, Noemi
Mancuso, Mariateresa
Tanori, Mirella
Colantoni, Eleonora
Vitali, Roberta
Diretto, Gianfranco
Lorenzo Rebenaque, Laura
Stronati, Laura
Negroni, Anna
author_facet Fiaschini, Noemi
Mancuso, Mariateresa
Tanori, Mirella
Colantoni, Eleonora
Vitali, Roberta
Diretto, Gianfranco
Lorenzo Rebenaque, Laura
Stronati, Laura
Negroni, Anna
author_sort Fiaschini, Noemi
collection PubMed
description A tight relationship between gut-liver diseases and brain functions has recently emerged. Bile acid (BA) receptors, bacterial-derived molecules and the blood-brain barrier (BBB) play key roles in this association. This study was aimed to evaluate how non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) impact the BA receptors Farnesoid X receptor (FXR) and Takeda G-protein coupled receptor 5 (TGR5) expression in the brain and to correlate these effects with circulating BAs composition, BBB integrity and neuroinflammation. A mouse model of NAFLD was set up by a high-fat and sugar diet, and NASH was induced with the supplementation of dextran-sulfate-sodium (DSS) in drinking water. FXR, TGR5 and ionized calcium-binding adaptor molecule 1 (Iba-1) expression in the brain was detected by immunohistochemistry, while Zonula occludens (ZO)-1, Occludin and Plasmalemmal Vesicle Associated Protein-1 (PV-1) were analyzed by immunofluorescence. Biochemical analyses investigated serum BA composition, lipopolysaccharide-binding protein (LBP) and S100β protein (S100β) levels. Results showed a down-regulation of FXR in NASH and an up-regulation of TGR5 and Iba-1 in the cortex and hippocampus in both treated groups as compared to the control group. The BA composition was altered in the serum of both treated groups, and LBP and S100β were significantly augmented in NASH. ZO-1 and Occludin were attenuated in the brain capillary endothelial cells of both treated groups versus the control group. We demonstrated that NAFLD and NASH provoke different grades of brain dysfunction, which are characterized by the altered expression of BA receptors, FXR and TGR5, and activation of microglia. These effects are somewhat promoted by a modification of circulating BAs composition and by an increase in LBP that concur to damage BBB, thus favoring neuroinflammation.
format Online
Article
Text
id pubmed-9697805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96978052022-11-26 Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier Fiaschini, Noemi Mancuso, Mariateresa Tanori, Mirella Colantoni, Eleonora Vitali, Roberta Diretto, Gianfranco Lorenzo Rebenaque, Laura Stronati, Laura Negroni, Anna Int J Mol Sci Article A tight relationship between gut-liver diseases and brain functions has recently emerged. Bile acid (BA) receptors, bacterial-derived molecules and the blood-brain barrier (BBB) play key roles in this association. This study was aimed to evaluate how non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) impact the BA receptors Farnesoid X receptor (FXR) and Takeda G-protein coupled receptor 5 (TGR5) expression in the brain and to correlate these effects with circulating BAs composition, BBB integrity and neuroinflammation. A mouse model of NAFLD was set up by a high-fat and sugar diet, and NASH was induced with the supplementation of dextran-sulfate-sodium (DSS) in drinking water. FXR, TGR5 and ionized calcium-binding adaptor molecule 1 (Iba-1) expression in the brain was detected by immunohistochemistry, while Zonula occludens (ZO)-1, Occludin and Plasmalemmal Vesicle Associated Protein-1 (PV-1) were analyzed by immunofluorescence. Biochemical analyses investigated serum BA composition, lipopolysaccharide-binding protein (LBP) and S100β protein (S100β) levels. Results showed a down-regulation of FXR in NASH and an up-regulation of TGR5 and Iba-1 in the cortex and hippocampus in both treated groups as compared to the control group. The BA composition was altered in the serum of both treated groups, and LBP and S100β were significantly augmented in NASH. ZO-1 and Occludin were attenuated in the brain capillary endothelial cells of both treated groups versus the control group. We demonstrated that NAFLD and NASH provoke different grades of brain dysfunction, which are characterized by the altered expression of BA receptors, FXR and TGR5, and activation of microglia. These effects are somewhat promoted by a modification of circulating BAs composition and by an increase in LBP that concur to damage BBB, thus favoring neuroinflammation. MDPI 2022-11-17 /pmc/articles/PMC9697805/ /pubmed/36430732 http://dx.doi.org/10.3390/ijms232214254 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fiaschini, Noemi
Mancuso, Mariateresa
Tanori, Mirella
Colantoni, Eleonora
Vitali, Roberta
Diretto, Gianfranco
Lorenzo Rebenaque, Laura
Stronati, Laura
Negroni, Anna
Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
title Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
title_full Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
title_fullStr Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
title_full_unstemmed Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
title_short Liver Steatosis and Steatohepatitis Alter Bile Acid Receptors in Brain and Induce Neuroinflammation: A Contribution of Circulating Bile Acids and Blood-Brain Barrier
title_sort liver steatosis and steatohepatitis alter bile acid receptors in brain and induce neuroinflammation: a contribution of circulating bile acids and blood-brain barrier
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697805/
https://www.ncbi.nlm.nih.gov/pubmed/36430732
http://dx.doi.org/10.3390/ijms232214254
work_keys_str_mv AT fiaschininoemi liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT mancusomariateresa liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT tanorimirella liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT colantonieleonora liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT vitaliroberta liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT direttogianfranco liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT lorenzorebenaquelaura liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT stronatilaura liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier
AT negronianna liversteatosisandsteatohepatitisalterbileacidreceptorsinbrainandinduceneuroinflammationacontributionofcirculatingbileacidsandbloodbrainbarrier